Pregnant women's choices for preventing respiratory syncytial virus (RSV)

被引:0
|
作者
Wang, Bing [1 ,2 ,3 ]
Lassi, Zohra [4 ,5 ]
Andraweera, Prabha [1 ,2 ,3 ]
Chen, Gang [6 ]
Ong, Jason J. [7 ,8 ]
Mcmillian, Mark [1 ,2 ,3 ]
Marshall, Helen [1 ,2 ,3 ]
机构
[1] Womens & Childrens Hlth Network, Vaccinol & Immunol Res Trials Unit, 72 King William Rd, Adelaide, SA 5006, Australia
[2] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia
[3] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia
[4] Univ Adelaide, Robinson Res Inst, Adelaide, Australia
[5] Univ Adelaide, Fac Hlth & Med Sci, Sch Publ Hlth, Adelaide, Australia
[6] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia
[7] Monash Univ, Sch Translat Med, Melbourne, Vic, Australia
[8] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England
关键词
RSV; Maternal vaccine; Vaccine attitudes; Qualitative; Vaccine promotion; VACCINATION; CHALLENGES; CHILDREN;
D O I
10.1016/j.vaccine.2025.126790
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in infants and can lead to severe respiratory distress, especially in very young infants. No specific treatments exist for RSV. However, new preventative strategies have become available including RSV vaccine for pregnant women and monoclonal antibody for infants. This study aimed to identify and understand barriers and facilitators to the uptake of a new RSV vaccine in pregnant women and determine their underlying choices for a maternal RSV immunisation program. Additionally, the study investigated choice for maternal vaccination or administration of a long-lasting monoclonal antibody to infants. Methods: Eligible participants were pregnant women residing in Australia and aged 18 years or older. Focus group discussions and individual online interviews were conducted and data were analysed using a thematic analysis approach. Results: A total of 34 pregnant women participated in online focus group discussions or interviews, with an average age of 34 years. The identified themes were categorised into four overarching domains: 1) motivators for vaccinating during pregnancy to safeguard their babies and prevent severe diseases, 2) barriers to vaccination including vaccine safety concerns, uncertainties regarding vaccine effectiveness, and vaccine hesitancy arising from COVID-19 vaccination experiences, 3) preferred vaccination promotion strategies, including constant reminders/prompts, personalised messages, campaign focusing on serious outcomes and using diverse/lay languages, recommendations from local obstetricians and health authorities, 4) clear vaccine recommendation policies and a preference for maternal immunisation over infant immunisation. Conclusions: The maternal RSV vaccination was generally welcomed and preferred by pregnant women in our study comparing to other strategies. Preferences for RSV program promotion included diversity in languages, "nudge" reminders, and recommendations from healthcare providers.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Preventing respiratory syncytial virus bronchiolitis in infants
    Robinson, Elisabeth
    Smyth, Rosalind
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
  • [42] Preventing hospitalizations for respiratory syncytial virus infection
    Robinson, Joan L.
    Le Saux, Nicole
    PAEDIATRICS & CHILD HEALTH, 2015, 20 (06) : 322 - 327
  • [43] Respiratory Syncytial Virus in Pregnant Women: Systematic Review and Meta-Analysis
    Ricco, Matteo
    Ferraro, Pietro
    Corrado, Silvia
    Zaniboni, Alessandro
    Satta, Elia
    Ranzieri, Silvia
    WOMEN, 2022, 2 (02): : 147 - 160
  • [44] Suppression of innate immunity to respiratory syncytial virus (RSV) in neonates
    Krishnan, S
    Halonen, M
    FASEB JOURNAL, 2004, 18 (05): : A1141 - A1141
  • [45] Phylogeny and population dynamics of respiratory syncytial virus (Rsv) A and B
    Martinelli, Marianna
    Frati, Elena Rosanna
    Zappa, Alessandra
    Ebranati, Erika
    Bianchi, Silvia
    Pariani, Elena
    Amendola, Antonella
    Zehender, Gianguglielmo
    Tanzi, Elisabetta
    VIRUS RESEARCH, 2014, 189 : 293 - 302
  • [46] The burden of respiratory syncytial virus (RSV) and the value of prevention - Introduction
    Welliver, RC
    JOURNAL OF PEDIATRICS, 2003, 143 (05): : S111 - S111
  • [47] Respiratory syncytial virus (RSV) infections in immunocompromized children.
    Chiang, AKS
    Chan, GCF
    Ha, SY
    Chan, KH
    BLOOD, 2004, 104 (11) : 410B - 410B
  • [48] Exploring the dynamics of respiratory syncytial virus (RSV) transmission in children
    Hogan, Alexandra B.
    Glass, Kathryn
    Moore, Hannah C.
    Anderssen, Robert S.
    THEORETICAL POPULATION BIOLOGY, 2016, 110 : 78 - 85
  • [49] Strategic priorities for respiratory syncytial virus (RSV) vaccine development
    Anderson, L. J.
    Dormitzer, P. R.
    Nokes, D. J.
    Rappuoli, R.
    Roca, A.
    Graham, B. S.
    VACCINE, 2013, 31 : B209 - B215
  • [50] RESPIRATORY SYNCYTIAL VIRUS (RSV) INDUCES DEGRANULATION OF ASTHMATIC EOSINOPHILS
    TRISTRAM, DA
    SUN, M
    WELLIVER, RC
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 333 - 333